IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States. and internationally. It offers microbiological and analytical testing, clinical packaging, and pharmacy services. The company also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, it offers mRNA and ADCs. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
Metrics to compare | IDT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIDTPeersSector | |
---|---|---|---|---|
P/E Ratio | −8.1x | −6.7x | −0.5x | |
PEG Ratio | −0.18 | −0.02 | 0.00 | |
Price/Book | 1.4x | 4.0x | 2.6x | |
Price / LTM Sales | 2.1x | 10.2x | 3.0x | |
Upside (Analyst Target) | - | 286.0% | 52.6% | |
Fair Value Upside | Unlock | 17.3% | 8.7% | Unlock |